An Open-Label Study of the Effect of an Ophthalmic Solution on Asteroid Hyalosis

An Open-Label Study of the Effect of C-KAD Ophthalmic Solution on Asteroid Hyalosis

Status

UNKNOWN

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00825942

Enrollment

Registered

2009-01-21

Start date

2008-07-31

Completion date

2009-11-30

Last updated

2009-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asteroid Hyalosis

Keywords

Asteroid hyalosis, Opthalmic Study

Brief summary

To determine the safety and initial efficacy of C-KAD ophthalmic solution in patients with asteroid hyalosis

Interventions

DRUGC-KAD Ophthalmic Solution

4 drops applied daily for 180 days

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

21 Years to 90 Years

Healthy volunteers

Inclusion criteria

* Presence of asteroid hyalosis

Exclusion criteria

* Active ocular infection * Glaucoma * Ocular hypertension * Ocular inflammatory disorders

Design outcomes

Primary

Measure	Time frame
Reduction in the number of asteroid bodies	180

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026